These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35347645)

  • 21. Alleviation of a polyglucosan storage disorder by enhancement of autophagic glycogen catabolism.
    Kakhlon O; Vaknin H; Mishra K; D'Souza J; Marisat M; Sprecher U; Wald-Altman S; Dukhovny A; Raviv Y; Da'adoosh B; Engel H; Benhamron S; Nitzan K; Sweetat S; Permyakova A; Mordechai A; Akman HO; Rosenmann H; Lossos A; Tam J; Minassian BA; Weil M
    EMBO Mol Med; 2021 Oct; 13(10):e14554. PubMed ID: 34486811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammation in Lafora Disease: Evolution with Disease Progression in Laforin and Malin Knock-out Mouse Models.
    López-González I; Viana R; Sanz P; Ferrer I
    Mol Neurobiol; 2017 Jul; 54(5):3119-3130. PubMed ID: 27041370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel GBE1 mutation and features of polyglucosan bodies autophagy in adult polyglucosan body disease.
    Sampaolo S; Esposito T; Gianfrancesco F; Napolitano F; Lombardi L; Lucà R; Roperto F; Di Iorio G
    Neuromuscul Disord; 2015 Mar; 25(3):247-52. PubMed ID: 25544507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological Modulation of Glutamatergic and Neuroinflammatory Pathways in a Lafora Disease Mouse Model.
    Mollá B; Heredia M; Campos Á; Sanz P
    Mol Neurobiol; 2022 Oct; 59(10):6018-6032. PubMed ID: 35835895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in lafora progressive myoclonus epilepsy.
    Delgado-Escueta AV
    Curr Neurol Neurosci Rep; 2007 Sep; 7(5):428-33. PubMed ID: 17764634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of leptin signaling reduces polyglucosan inclusions and seizure susceptibility in a mouse model for Lafora disease.
    Rai A; Mishra R; Ganesh S
    Hum Mol Genet; 2017 Dec; 26(24):4778-4785. PubMed ID: 28973665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The carbohydrate-binding domain of Lafora disease protein targets Lafora polyglucosan bodies.
    Ganesh S; Tsurutani N; Suzuki T; Hoshii Y; Ishihara T; Delgado-Escueta AV; Yamakawa K
    Biochem Biophys Res Commun; 2004 Jan; 313(4):1101-9. PubMed ID: 14706656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulators of Neuroinflammation Have a Beneficial Effect in a Lafora Disease Mouse Model.
    Mollá B; Heredia M; Sanz P
    Mol Neurobiol; 2021 Jun; 58(6):2508-2522. PubMed ID: 33447969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epm2a
    Burgos DF; Sciaccaluga M; Worby CA; Zafra-Puerta L; Iglesias-Cabeza N; Sánchez-Martín G; Prontera P; Costa C; Serratosa JM; Sánchez MP
    Neurobiol Dis; 2023 Jun; 181():106119. PubMed ID: 37059210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Astrocytes and neurons produce distinct types of polyglucosan bodies in Lafora disease.
    Augé E; Pelegrí C; Manich G; Cabezón I; Guinovart JJ; Duran J; Vilaplana J
    Glia; 2018 Oct; 66(10):2094-2107. PubMed ID: 30152044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laforin preferentially binds the neurotoxic starch-like polyglucosans, which form in its absence in progressive myoclonus epilepsy.
    Chan EM; Ackerley CA; Lohi H; Ianzano L; Cortez MA; Shannon P; Scherer SW; Minassian BA
    Hum Mol Genet; 2004 Jun; 13(11):1117-29. PubMed ID: 15102711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of intracerebroventricular administration of alglucosidase alfa in two mouse models of Lafora disease: Relevance for clinical practice.
    Zafra-Puerta L; Colpaert M; Iglesias-Cabeza N; Burgos DF; Sánchez-Martín G; Gentry MS; Sánchez MP; Serratosa JM
    Epilepsy Res; 2024 Feb; 200():107317. PubMed ID: 38341935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polyglucosan storage myopathies.
    Hedberg-Oldfors C; Oldfors A
    Mol Aspects Med; 2015 Dec; 46():85-100. PubMed ID: 26278982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycogen metabolism in tissues from a mouse model of Lafora disease.
    Wang W; Lohi H; Skurat AV; DePaoli-Roach AA; Minassian BA; Roach PJ
    Arch Biochem Biophys; 2007 Jan; 457(2):264-9. PubMed ID: 17118331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Astrocytic glycogen accumulation drives the pathophysiology of neurodegeneration in Lafora disease.
    Duran J; Hervera A; Markussen KH; Varea O; López-Soldado I; Sun RC; Del Río JA; Gentry MS; Guinovart JJ
    Brain; 2021 Sep; 144(8):2349-2360. PubMed ID: 33822008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Astrocytes: new players in progressive myoclonus epilepsy of Lafora type.
    Rubio-Villena C; Viana R; Bonet J; Garcia-Gimeno MA; Casado M; Heredia M; Sanz P
    Hum Mol Genet; 2018 Apr; 27(7):1290-1300. PubMed ID: 29408991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycogen in Astrocytes and Neurons: Physiological and Pathological Aspects.
    Duran J; Gruart A; López-Ramos JC; Delgado-García JM; Guinovart JJ
    Adv Neurobiol; 2019; 23():311-329. PubMed ID: 31667813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic depletion of the malin E3 ubiquitin ligase in mice leads to lafora bodies and the accumulation of insoluble laforin.
    DePaoli-Roach AA; Tagliabracci VS; Segvich DM; Meyer CM; Irimia JM; Roach PJ
    J Biol Chem; 2010 Aug; 285(33):25372-81. PubMed ID: 20538597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel image-based high-throughput screening assay discovers therapeutic candidates for adult polyglucosan body disease.
    Solmesky LJ; Khazanov N; Senderowitz H; Wang P; Minassian BA; Ferreira IM; Yue WW; Lossos A; Weil M; Kakhlon O
    Biochem J; 2017 Sep; 474(20):3403-3420. PubMed ID: 28827282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polyglucosan bodies in intramuscular nerve branches are a poor predictor of GBE1 mutation and adult polyglucosan body disease.
    Furtado LV; Kadri S; Wurst MN; Long BC; Segal JP; Pytel P
    Muscle Nerve; 2016 Mar; 53(3):473-5. PubMed ID: 26670585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.